New eye drop trial targets common, irritating eyelid condition
Disease control
Recruiting now
This study is testing a new eye drop treatment called APT-001 for people with blepharitis, a condition that causes red, irritated, and crusty eyelids. About 100 participants will be randomly assigned to receive either the real treatment or a control substance (with no active drug…
Phase: PHASE2 • Sponsor: Aperta Biosciences, LLC • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC